Biosimilars advancements: Moving on to the future.

Biosimilars advancements: Moving on to the future.

Item
http://www.wikidata.org/entity/Q38364577
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published EvidenceRecent Advances in Application of Pharmacogenomics for BiotherapeuticsCharacterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody.Predictive glycoengineering of biosimilars using a Markov chain glycosylation model.Biosimilars: Key regulatory considerations and similarity assessment tools.Analytical characterization of recombinant hCG and comparative studies with reference product.The process defines the product: what really matters in biosimilar design and production?Enhanced immunization techniques to obtain highly specific monoclonal antibodies.Identifying the differences in mechanisms of mycophenolic acid controlling fucose content of glycoproteins expressed in different CHO cell lines.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.The biosimilars journey: current status and ongoing challenges
P2860

Biosimilars advancements: Moving on to the future.

Item
http://www.wikidata.org/entity/Q38364577
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Biosimilars advancements: Moving on to the future.
@en
type
label
Biosimilars advancements: Moving on to the future.
@en
prefLabel
Biosimilars advancements: Moving on to the future.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Biosimilars advancements: Moving on to the future
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932